Nitidine chloride inhibits G2/M phase by regulating the p53/14-3-3 Sigma/CDK1 axis for hepatocellular carcinoma treatment,Heliyon

当前位置： X-MOL 学术 › Heliyon › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Nitidine chloride inhibits G2/M phase by regulating the p53/14-3-3 Sigma/CDK1 axis for hepatocellular carcinoma treatment
Heliyon ( IF 3.4 ) Pub Date : 2024-01-03 , DOI: 10.1016/j.heliyon.2024.e24012
Bo Zhang ₁ , Bo Zhou ₁ , Guihong Huang _{2,

3,

4} , Jing'an Huang ₁ , Xiaoxin Lin ₁ , Zonghuai Li ₁ , Yuanchu Lian ₁ , Qiujie Huang ₅ , Yong Ye _{6,

7}

Affiliation

Liver cancer had become the sixth most common cancer. Nitidine chloride (NC) has demonstrated promising anti-HCC properties; however, further elucidation of its mechanism of action is necessary.

中文翻译：